Efficacy of Laser Acupuncture on Carpal Tunnel Syndrome Following Hand Flexor Tendon Repair

N/ANot Yet RecruitingNCT07014774

Cairo University60 enrolled

Overview

The purpose of this study is to determine the efficacy of laser acupuncture in alleviating CTS symptoms following flexor tendon repair in the hand.

This study holds significant importance for clinical practice, patient care, and research. * Clinical Practice: It provides a potential framework for physical therapists to design targeted and effective interventions for laser acupuncture on CTS following flexor tendon repair in the hand. * Patient Care: Improved rehabilitation outcomes can enhance patients' physical functionality, independence, and overall quality of life, addressing a critical gap in post-operative complications. * Research Advancement: By contributing to the limited body of literature on laser acupuncture in this context, the study can stimulate further research and innovation in carpal tunnel syndrome following hand flexor tendon repair.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Laser Acupuncture Flexor Tendon Repair Hand Surgery Carpal Tunnel Syndrome (CTS)

Interventions

Laser acupunctureDEVICE

Laser acupuncture is a modern, non-invasive approach to acupuncture that uses low-level laser therapy (LLLT) instead of traditional needles to stimulate acupuncture points. This technique combines the principles of traditional Chinese medicine with modern technology to provide pain relief and promote healing (Chon et al., 2019). * Device: UNIPHY PHYACTION 740, made in EEC device. * Laser type: Gallium aluminum arsenide laser. * Wavelength: 808 nm. * Power Output: 200 mW. * Dose/energy density: 4J/point. * Frequency of treatment: Three times weekly for 8 weeks. * Duration: 12 min. * Cumulative dose: 48J/point. * Target Acupuncture Points: Key points for CTS: PC4 (Ximen), PC6 (Neiguan), PC7 (Daling), PC8 (Laogong), LI4 (Hegu), LI10 (Shousanli), LI11 (Quchi), HT-2 (Qingling), HT7 (Shenmen), HT-8 (Shaofu), LU9 (Taiyuan) and LU10 (Yuji)

Traditional TherapyOTHER

* Splinting/Bracing: Patients in the two groups will advised to wear a static wrist splint locked at 0\_ wrist flexion for at least 8 h at night throughout the entire length of the study as the primary management which reduce pressure on the median nerve. * Physical Therapy: Engaging in specific exercises, such as nerve glide exercises and wrist stretches, can improve mobility and reduce symptoms. These exercises aim to restore normal movement of the median nerve and alleviate compression

Eligibility

Sex: ALLMin age: 20 YearsMax age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adults aged 20-40 years who have undergone flexor tendon repair surgery. * Patients who have undergone primary or secondary repair of flexor tendons in the hand at zone 4 (zone of carpal tunnel as it often be complicated by postoperative adhesions due to close quarters and synovial sheath of the carpal tunnel) (Fulchignoni C et al., 2020). * Surgery occurred within a specific timeframe, often within 6-12 weeks prior to inclusion (Peters SE, Jha B, Ross M., 2021). * Patient have clinical and electro diagnostic evidence of CTS. * All patients enrolled to the study will have their informed consent. Exclusion Criteria: * Pre-existing neurological disorders. * Systemic illnesses affecting nerve function (e.g., diabetes). * Contraindications to laser therapy. * Pregnancy or breastfeeding. * Active infections or open wounds in the hand or wrist. * Previous history of carpal tunnel release surgery or received an injection of steroid for CTS. * Previous history of brachial plexus injury or median nerve injury. * Other severe neurological or musculoskeletal conditions. * Epilepsy or any psychological disorders. * Cancer. * Spots over the treated points. * Pacemaker or implanted devices.

Locations (1)

Learning Hospitals Al Kaser Al Ayni Hospitals

Cairo, Egypt

Outcomes

Primary Outcomes

Symptom Relief:

Measured by the Visual Analog Scale (VAS) for pain, numbness, and tingling.

Time frame: At baseline and after 8 weeks

Secondary Outcomes

- Grip Strength:

Measured with a hand dynamometer to assess the strength of hand muscles.

Time frame: Measured at baseline and at the end of the intervention (8 weeks).

- Nerve Conduction Velocity (NCV):

Measured to assess median nerve conduction before and after the intervention

Time frame: baseline and 8 weeks.

Central Contacts

Mahmoud Adel Abde-Hakim Amin, Physical Therapist

CONTACT

+201002737990 Dr.Mahmoud.A.Hakim@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.